MCID: ACT036
MIFTS: 36

Acute Cholangitis

Categories: Gastrointestinal diseases

Aliases & Classifications for Acute Cholangitis

MalaCards integrated aliases for Acute Cholangitis:

Name: Acute Cholangitis 12 15 71

Classifications:



External Ids:

Disease Ontology 12 DOID:14271
NCIt 49 C35334
SNOMED-CT 67 6215006
UMLS 71 C0267917

Summaries for Acute Cholangitis

MalaCards based summary : Acute Cholangitis is related to ascending cholangitis and toxic shock syndrome. An important gene associated with Acute Cholangitis is TREM1 (Triggering Receptor Expressed On Myeloid Cells 1), and among its related pathways/superpathways are Folate Metabolism and Overview of nanoparticle effects. The drugs Anti-Bacterial Agents and Antibiotics, Antitubercular have been mentioned in the context of this disorder. Affiliated tissues include liver, pancreas and lung.

Related Diseases for Acute Cholangitis

Diseases in the Cholangitis family:

Acute Cholangitis Chronic Cholangitis

Diseases related to Acute Cholangitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 488, show less)
# Related Disease Score Top Affiliating Genes
1 ascending cholangitis 31.5 GPT GGTLC3 F2 CRP ALB
2 toxic shock syndrome 30.6 TREM1 IL6 IL1RN CRP
3 cholecystitis 30.5 MUC5AC GPT F2 ALB
4 disseminated intravascular coagulation 30.3 IL6 GPT F2 CRP
5 acute kidney failure 30.2 GPT F2 ALB
6 pancreatitis 30.2 IL6 GGT1 CRP ALB
7 acute pancreatitis 30.1 IL6 IL1RN GPT CRP ALB
8 bacterial meningitis 30.0 IL6 CRP ALB
9 fascioliasis 29.9 GPT GGT1 ALB
10 fatty liver disease, nonalcoholic 1 29.9 GPT GGT1
11 peritonitis 29.9 IL6 F2 CRP ALB
12 cholelithiasis 29.8 GPT GGT1 CRP ALB
13 meningitis 29.8 IL6 CRP CALCA ALB
14 cholestasis 29.8 IL6 GPT GGT1 F2 ALB
15 septic arthritis 29.8 TREM1 IL6 CRP CALCA
16 liver cirrhosis 29.7 GPT GGT1 F2 ALB
17 cholangitis 29.7 IL6 GPT GGT1 F2 CRP CEACAM5
18 ileus 29.7 IL6 F2 CRP CALCA
19 acalculous cholecystitis 29.7 GPT F2 CRP ALB
20 portal hypertension 29.7 GPT F2 ALB
21 urinary tract obstruction 29.6 GGT1 CRP ALB
22 bronchitis 29.6 IL6 CRP CALCA ALB
23 bronchopneumonia 29.6 IL6 GPT CRP ALB
24 kawasaki disease 29.5 IL6 GPT CRP ALB
25 endocarditis 29.5 IL6 F2 CRP ALB
26 diarrhea 29.5 IL6 GPT CALCA ALB
27 obstructive jaundice 29.5 IL6 GPT GGT1 F2 CRP ALB
28 peptic ulcer disease 29.4 TREM1 MUC5AC IL1RN ALB
29 suppurative cholangitis 29.3 TREM1 GPT GGTLC3 GGT2 GGT1
30 biliary atresia 29.3 GPT GGT1 F2 ALB
31 gastroenteritis 29.3 IL6 IL1RN CRP CALCA ALB
32 bacterial pneumonia 29.3 IL6 GPT CRP CALCA ALB
33 acute cystitis 29.1 IL6 GPT F2 CRP ALB
34 fatty liver disease 29.0 IL6 GPT GGT1 CRP ALB
35 liver disease 29.0 IL6 GPT GGT1 F2 ALB
36 cholangiocarcinoma 28.9 MUC5AC IL6 GGT1 CEACAM5
37 respiratory failure 28.7 MUC5AC IL6 IL1RN GPT F2 CRP
38 sclerosing cholangitis 28.5 IL6 GPT GGT1 F2 CEACAM5 ALB
39 bile duct cancer 28.4 MUC5AC IL6 GPT CEACAM5 ALB
40 thrombocytopenia 28.3 IL6 IL1RN GPT GGT1 F2 CRP
41 bilirubin metabolic disorder 28.1 GPT GGTLC3 GGT2 GGT1 F2 CRP
42 bile duct cysts 28.0 GPT GGTLC3 GGT2 GGT1 CEACAM5
43 choledocholithiasis 27.9 GPT GGTLC3 GGT2 GGT1 F2 CRP
44 gallbladder disease 27.1 GPT GGTLC3 GGT2 GGT1 CRP CEACAM5
45 biliary tract disease 26.8 IL6 GPT GGTLC3 GGT2 GGT1 F2
46 bullous impetigo 10.5 IL6 CALCA
47 sepsis in premature infants 10.5 CRP CALCA
48 systemic onset juvenile idiopathic arthritis 10.5 IL1RN IL1RAPL2
49 indolent myeloma 10.4 IL6 IL1RN
50 cold agglutinin disease 10.4 IL6 CRP
51 gorham's disease 10.4 IL6 CALCA
52 prosthetic joint infection 10.4 IL6 CRP
53 uremic pruritus 10.4 IL6 CRP
54 systemic autoimmune disease 10.4 IL6 CRP
55 sudden sensorineural hearing loss 10.4 IL6 F2
56 neurogenic arthropathy 10.4 CRP CALCA
57 hepatoportal sclerosis 10.4 GPT F2
58 rheumatoid arthritis interstitial lung disease 10.4 IL1RN CRP
59 intestinal tuberculosis 10.4 CRP ALB
60 achenbach syndrome 10.4 F2 CRP
61 orbital osteomyelitis 10.4 F2 CRP
62 small intestine diverticulitis 10.4 F2 CRP
63 discitis 10.4 CRP CALCA
64 dipetalonemiasis 10.4 GPT ALB
65 hyper-igd syndrome 10.4 IL1RN CRP
66 gallbladder disease 1 10.3
67 synovial angioma 10.3 F2 CRP
68 renal pelvis squamous cell carcinoma 10.3 F2 CRP
69 tracheitis 10.3 IL6 CRP
70 blue toe syndrome 10.3 F2 CRP
71 chronic duodenal ileus 10.3 CRP ALB
72 non-a-e hepatitis 10.3 F2 ALB
73 antipyrine metabolism 10.3 F2 ALB
74 pyridoxine deficiency anemia 10.3 GPT F2
75 hematocele of tunica vaginalis testis 10.3 F2 CRP
76 heterophyiasis 10.3 GPT ALB
77 tinea unguium 10.3 GPT CRP
78 atypical depressive disorder 10.3 IL6 CRP
79 cavernous sinus thrombosis 10.3 F2 CRP
80 lemierre's syndrome 10.3 F2 CRP
81 osteomyelitis 10.3 IL6 IL1RN CALCA
82 parenteral nutrition-associated cholestasis 10.3 GPT GGT1
83 hypopyon 10.3 IL6 CRP
84 fournier gangrene 10.3 F2 ALB
85 baastrup's syndrome 10.3 IL1RN CRP
86 intracranial sinus thrombosis 10.3 F2 CRP
87 root resorption 10.3 IL6 IL1RN CALCA
88 relapsing polychondritis 10.3 TREM1 IL6 CRP
89 cholesterol embolism 10.3 F2 CRP
90 peptic ulcer perforation 10.3 CRP ALB
91 abducens nerve disease 10.3 F2 CRP
92 somatoform disorder 10.3 IL6 IL1RN CALCA
93 spondylitis 10.3 IL6 IL1RN CRP
94 gastric ulcer 10.3 IL6 IL1RN CALCA
95 polyradiculopathy 10.3 IL6 CRP CALCA
96 fasciitis 10.3 IL6 IL1RN CRP
97 dengue shock syndrome 10.3 IL6 IL1RN IL1RAPL2
98 cryopyrin-associated periodic syndrome 10.3 IL6 IL1RN CRP
99 juvenile arthritis 10.3 IL6 IL1RAPL2 CRP
100 meningovascular neurosyphilis 10.3 CRP ALB
101 duodenal ulcer 10.3 IL6 IL1RN CALCA
102 aortitis 10.3 IL6 IL1RN CRP
103 tenosynovitis 10.3 IL6 IL1RN CRP
104 synovitis 10.3 IL6 IL1RN CRP
105 chondromalacia 10.3 IL6 IL1RN CRP
106 viral meningitis 10.3 IL6 CRP CALCA
107 scleral disease 10.3 IL6 IL1RN CRP
108 nodular goiter 10.3 IL6 CRP CALCA
109 branch retinal artery occlusion 10.3 F2 CRP
110 central nervous system vasculitis 10.2 IL6 IL1RN CRP
111 anterior scleritis 10.2 IL1RN IL1RAPL2 CRP
112 scleritis 10.2 IL1RN IL1RAPL2 CRP
113 chronic recurrent multifocal osteomyelitis 10.2 IL6 IL1RN CRP
114 ankylosing spondylitis 3 10.2 CRP ALB
115 cervical adenitis 10.2 IL1RN CRP
116 inflammatory and toxic neuropathy 10.2 CRP ALB
117 sebaceous gland disease 10.2 IL6 IL1RN CRP
118 klebsiella pneumonia 10.2 CRP ALB
119 schnitzler syndrome 10.2 IL1RN IL1RAPL2 CRP
120 pustulosis of palm and sole 10.2 IL1RN CRP
121 hypertensive encephalopathy 10.2 F2 ALB
122 aseptic meningitis 10.2 IL1RN CRP CALCA
123 polyarteritis nodosa 10.2 IL6 GPT CRP
124 subacute bacterial endocarditis 10.2 CRP ALB
125 brucellosis 10.2 IL6 IL1RN CRP
126 aspiration pneumonitis 10.2 CRP ALB
127 autonomic nervous system disease 10.2 IL6 CALCA ALB
128 covid-19 10.2 IL6 GPT CRP
129 fibromyalgia 10.2 IL6 CRP CALCA
130 chlamydia pneumonia 10.2 IL6 CRP
131 yellow fever 10.2 IL6 IL1RN CRP
132 temporal arteritis 10.2 IL6 IL1RN CRP
133 mastoiditis 10.2 F2 CRP
134 uveal disease 10.2 IL6 IL1RN CRP
135 pain agnosia 10.2 IL6 CALCA ALB
136 agnosia 10.2 IL6 CALCA ALB
137 familial mediterranean fever 10.2 IL6 IL1RN CRP
138 cap polyposis 10.2 MUC5AC ALB
139 hypertensive retinopathy 10.2 CRP ALB
140 retinal vascular occlusion 10.2 IL6 F2 CRP
141 autoimmune disease of cardiovascular system 10.2 IL6 F2 CRP
142 generalized atherosclerosis 10.2 IL6 CRP ALB
143 adult respiratory distress syndrome 10.2 IL6 F2 CALCA
144 retinal artery occlusion 10.2 IL6 F2 CRP
145 severe acute respiratory syndrome 10.2 IL6 GPT CRP
146 lung abscess 10.2 IL6 CRP ALB
147 background diabetic retinopathy 10.2 IL6 CRP ALB
148 hantavirus hemorrhagic fever with renal syndrome 10.2 IL6 CRP ALB
149 leptospirosis 10.2 IL6 F2 CRP
150 emphysematous cholecystitis 10.2 GPT F2 CRP
151 primary systemic mycosis 10.2 IL6 CRP ALB
152 blood group, globoside system 10.2 IL6 CRP ALB
153 pneumocystosis 10.2 IL6 CRP ALB
154 hypersensitivity vasculitis 10.2 IL6 CRP ALB
155 pyelitis 10.2 IL6 CRP ALB
156 intussusception 10.2 IL6 CRP ALB
157 spondyloarthropathy 1 10.2 IL1RN IL1RAPL2 CRP
158 endophthalmitis 10.2 IL6 CRP ALB
159 hypersensitivity reaction type iii disease 10.2 IL6 CRP ALB
160 papilledema 10.2 IL1RN F2 CRP
161 chronic pyelonephritis 10.2 CRP CALCA ALB
162 chronic ulcer of skin 10.2 IL6 CRP ALB
163 chickenpox 10.2 IL6 CRP ALB
164 periodontitis 10.2 IL6 IL1RN CRP
165 autoimmune disease of blood 10.2 IL6 CRP ALB
166 purpura 10.2 IL6 F2 CRP
167 bacteriuria 10.2 IL6 CRP ALB
168 coccidiosis 10.1 IL6 CRP ALB
169 pulmonary tuberculosis 10.1 IL6 CRP ALB
170 salmonellosis 10.1 IL6 GPT ALB
171 constrictive pericarditis 10.1 IL1RN CRP ALB
172 mastitis 10.1 IL6 IL1RN ALB
173 opportunistic mycosis 10.1 IL6 CRP ALB
174 polyclonal hypergammaglobulinemia 10.1 IL6 CRP
175 chronic meningitis 10.1 IL1RN CRP ALB
176 spinal cord disease 10.1 IL6 CRP ALB
177 toxic megacolon 10.1 CRP ALB
178 meningoencephalitis 10.1 IL6 CRP ALB
179 fungal infectious disease 10.1 IL6 CRP ALB
180 lymph node disease 10.1 IL6 CRP ALB
181 critical illness polyneuropathy 10.1 GPT CRP ALB
182 appendicitis 10.1 IL6 CRP ALB
183 nose disease 10.1 IL6 CRP ALB
184 commensal bacterial infectious disease 10.1 IL6 CRP ALB
185 placenta disease 10.1 IL6 F2 CRP
186 central retinal artery occlusion 10.1 F2 CRP
187 hair disease 10.1 IL6 GPT ALB
188 coronary stenosis 10.1 IL6 CRP ALB
189 filariasis 10.1 IL6 CRP ALB
190 hydrops of gallbladder 10.1 GPT CRP ALB
191 eclampsia 10.1 IL6 F2 ALB
192 volvulus of midgut 10.1 GPT CRP ALB
193 blood protein disease 10.1 IL6 F2 ALB
194 cranial nerve disease 10.1 IL6 CRP ALB
195 drug allergy 10.1 GPT CRP ALB
196 hepatic infarction 10.1 GPT F2 ALB
197 extrapulmonary tuberculosis 10.1 IL1RN CRP ALB
198 infantile liver failure syndrome 1 10.1 GPT F2 ALB
199 urolithiasis 10.1 IL6 F2 ALB
200 retinal vascular disease 10.1 IL6 CRP ALB
201 hepatic coma 10.1 GPT F2 ALB
202 plasmodium falciparum malaria 10.1 IL6 CRP ALB
203 intracranial berry aneurysm 10.1 IL6 CRP ALB
204 epidural abscess 10.1 F2 CRP ALB
205 mediastinitis 10.1 F2 CRP ALB
206 intracranial embolism 10.1 F2 CRP ALB
207 acute liver failure 10.1 GPT F2 ALB
208 drug-induced hepatitis 10.1 GPT F2 ALB
209 gastritis, familial giant hypertrophic 10.1 MUC5AC ALB
210 autoimmune disease of musculoskeletal system 10.1 IL6 CRP ALB
211 active peptic ulcer disease 10.1 F2 CRP ALB
212 chorioamnionitis 10.1 TREM1 IL6 IL1RN CRP
213 hypersplenism 10.1 GPT F2 ALB
214 uremia 10.1 IL6 CRP ALB
215 hepatorenal syndrome 10.1 GPT F2 ALB
216 pleural empyema 10.1 F2 CRP ALB
217 trypanosomiasis 10.1 IL6 GPT ALB
218 cardiac tamponade 10.1 F2 CRP ALB
219 tricuspid valve insufficiency 10.1 F2 CRP ALB
220 acute kidney tubular necrosis 10.1 IL6 GGT1 ALB
221 tricuspid valve disease 10.1 F2 CRP ALB
222 erysipelas 10.1 IL6 IL1RN CRP CALCA
223 bacterial infectious disease 10.1 TREM1 IL6 IL1RN CRP
224 hydronephrosis 10.1 IL6 CRP ALB
225 thrombophlebitis 10.1 F2 CRP ALB
226 bacterial sepsis 10.1 IL6 IL1RN CRP CALCA
227 metal metabolism disorder 10.1 GPT F2 ALB
228 mitral valve insufficiency 10.1 F2 CRP ALB
229 peptic esophagitis 10.1 IL6 ALB
230 echinococcosis 10.1
231 48,xyyy 10.1
232 adult-onset still's disease 10.1 IL6 IL1RN IL1RAPL2 CRP
233 proteasome-associated autoinflammatory syndrome 1 10.0 IL6 IL1RN IL1RAPL2 CRP
234 duodenitis 10.0 CRP ALB
235 alpha-1-antitrypsin deficiency 10.0 GPT F2 ALB
236 arthropathy 10.0 IL6 IL1RN IL1RAPL2 CRP
237 infective endocarditis 10.0 TREM1 IL6 F2 CRP
238 psoriatic arthritis 10.0 IL6 IL1RN IL1RAPL2 CRP
239 heart conduction disease 10.0 F2 CRP ALB
240 calcinosis 10.0 MUC5AC GPT CALCA
241 bronchiolitis 10.0 MUC5AC IL6 CRP
242 homocysteinemia 10.0 F2 CRP ALB
243 muscular disease 10.0 IL6 CRP ALB
244 gestational diabetes 10.0 IL6 CRP ALB
245 common cold 10.0 MUC5AC IL6 ALB
246 portal vein thrombosis 10.0
247 keratoconjunctivitis 10.0 MUC5AC IL6 ALB
248 heart valve disease 10.0 F2 CRP ALB
249 severe cutaneous adverse reaction 10.0 MUC5AC GPT CRP
250 decubitus ulcer 10.0 IL6 CRP CALCA ALB
251 pulmonary embolism 10.0 F2 CRP ALB
252 polyneuropathy 10.0 IL6 CRP CALCA ALB
253 thyroid angiosarcoma 10.0 CEACAM5 CALCA
254 takayasu arteritis 10.0 IL6 IL1RN F2 CRP
255 colon neuroendocrine neoplasm 10.0 CEACAM5 CALCA
256 bone resorption disease 10.0 IL6 CRP CALCA ALB
257 tetanus 10.0 IL6 CRP ALB
258 bone remodeling disease 10.0 IL6 CRP CALCA ALB
259 pericardial tuberculosis 10.0 CRP CEACAM5
260 nasal cavity olfactory neuroblastoma 10.0 CEACAM5 CALCA
261 atrial heart septal defect 10.0 F2 CRP ALB
262 necrotizing fasciitis 10.0 IL6 IL1RN CRP ALB
263 hypersensitivity reaction type iv disease 10.0 IL6 IL1RN CRP ALB
264 pericarditis 10.0 IL6 IL1RN CRP ALB
265 hellp syndrome 10.0 IL6 GPT F2 CRP
266 brain edema 9.9 IL6 IL1RN CRP ALB
267 intestinal perforation 9.9 IL6 GPT CRP ALB
268 apnea, obstructive sleep 9.9 IL6 GPT CRP ALB
269 prediabetes syndrome 9.9 IL6 GPT CRP ALB
270 juvenile rheumatoid arthritis 9.9 IL6 IL1RN CRP ALB
271 sarcomatous intrahepatic cholangiocarcinoma 9.9 GPT CEACAM5
272 bone inflammation disease 9.9 IL6 IL1RN CRP ALB
273 muckle-wells syndrome 9.9 IL1RN IL1RAPL2 CRP ALB
274 end stage renal disease 9.9 IL6 IL1RN CRP ALB
275 parasitic protozoa infectious disease 9.9 IL6 GPT CRP ALB
276 sleep apnea 9.9 IL6 GPT CRP ALB
277 primary bacterial infectious disease 9.9 IL6 GPT CRP ALB
278 optic nerve disease 9.9 IL6 CRP ALB
279 leukocyte disease 9.9 IL6 GPT CRP ALB
280 patent foramen ovale 9.9 F2 CRP ALB
281 dengue hemorrhagic fever 9.9 IL6 GPT F2 ALB
282 hepatic encephalopathy 9.9 IL6 GPT F2 ALB
283 alcoholic liver cirrhosis 9.9 IL6 GPT F2 ALB
284 integumentary system disease 9.9 IL6 GPT CRP ALB
285 overnutrition 9.9 IL6 GPT CRP ALB
286 amyloidosis 9.9 IL6 IL1RN CRP ALB
287 melioidosis 9.9
288 thrombosis 9.9
289 intrahepatic cholangiocarcinoma 9.9
290 adenoma 9.9
291 afferent loop syndrome 9.9
292 collagen disease 9.9
293 47,xyy 9.9
294 congenital hepatic fibrosis 9.9
295 parotitis 9.9 CRP ALB
296 wilson disease 9.9 IL6 GPT F2 ALB
297 endocardium disease 9.9 IL6 F2 CRP ALB
298 glucose metabolism disease 9.9 IL6 GPT CRP ALB
299 intermittent claudication 9.9 IL6 F2 CRP ALB
300 glucose intolerance 9.9 IL6 GPT CRP ALB
301 metabolic acidosis 9.9 IL6 GPT F2 ALB
302 leishmaniasis 9.9 IL6 GPT CRP ALB
303 acquired metabolic disease 9.9 IL6 GPT CRP ALB
304 nutritional deficiency disease 9.9 IL6 F2 CRP ALB
305 sickle cell anemia 9.9 IL6 F2 CRP ALB
306 thrombocytosis 9.9 IL6 F2 CRP ALB
307 peripheral vascular disease 9.9 IL6 F2 CRP ALB
308 upper respiratory tract disease 9.9 IL6 CRP ALB
309 speech and communication disorders 9.9 IL6 F2 CRP ALB
310 acquired immunodeficiency syndrome 9.9 IL6 CRP ALB
311 external ear carcinoma 9.9 CRP CEACAM5 CALCA
312 ankylosing spondylitis 1 9.9 GPT F2 CRP ALB
313 splenic abscess 9.9 GPT F2 CRP ALB
314 urinary bladder villous adenoma 9.9 MUC5AC CEACAM5
315 splenic infarction 9.9 GPT F2 CRP ALB
316 paralytic ileus 9.9 GPT F2 CRP ALB
317 kwashiorkor 9.9 GPT F2 CRP ALB
318 analbuminemia 9.9 GPT F2 CRP ALB
319 anuria 9.9 GPT F2 CRP ALB
320 mucinous intrahepatic cholangiocarcinoma 9.9 MUC5AC CEACAM5
321 vaginal discharge 9.9 IL6 CRP CEACAM5
322 bile duct cystadenocarcinoma 9.8 MUC5AC CEACAM5
323 non-alcoholic steatohepatitis 9.8 IL6 GPT GGT1 ALB
324 atrial fibrillation 9.8 IL6 F2 CRP ALB
325 biliary papillomatosis 9.8 MUC5AC CEACAM5
326 bile duct mucoepidermoid carcinoma 9.8 MUC5AC CEACAM5
327 bile reflux 9.8 MUC5AC ALB
328 cholecystolithiasis 9.8 GPT CRP CEACAM5
329 biliary tract benign neoplasm 9.8 MUC5AC CEACAM5
330 pancreatic mucinous cystadenoma 9.8 MUC5AC CEACAM5
331 abdominal obesity-metabolic syndrome quantitative trait locus 2 9.8 IL6 CRP
332 ovarian mucinous neoplasm 9.8 MUC5AC CEACAM5
333 tumor of exocrine pancreas 9.8 MUC5AC CEACAM5
334 diverticulitis 9.8 MUC5AC IL6 CRP ALB
335 middle ear disease 9.8 MUC5AC IL6 CRP ALB
336 stroke, ischemic 9.8 IL6 F2 CRP ALB
337 stomach disease 9.8 MUC5AC IL6 CRP ALB
338 marantic endocarditis 9.8 F2 CRP CEACAM5
339 hyperuricemia 9.8 GPT GGT1 CRP ALB
340 hepatic tuberculosis 9.8 GPT GGT1 F2 ALB
341 bronchial disease 9.8 MUC5AC IL6 CRP ALB
342 hepatitis e 9.8 GPT GGT1 F2 ALB
343 hepatitis a 9.8 GPT GGT1 F2 ALB
344 klatskin's tumor 9.8 GPT CEACAM5 ALB
345 schistosomiasis 9.8 GPT GGT1 F2 ALB
346 hepatocellular carcinoma 9.8
347 crigler-najjar syndrome, type i 9.8
348 pancreatic agenesis 1 9.8
349 ascaris lumbricoides infection 9.8
350 crigler-najjar syndrome, type ii 9.8
351 spondylocostal dysostosis 3, autosomal recessive 9.8
352 pontine tegmental cap dysplasia 9.8
353 leptin deficiency or dysfunction 9.8
354 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
355 autosomal recessive disease 9.8
356 myelomeningocele 9.8
357 microinvasive gastric cancer 9.8
358 hydrocephalus 9.8
359 listeriosis 9.8
360 allergic hypersensitivity disease 9.8
361 alveolar echinococcosis 9.8
362 panniculitis 9.8
363 pneumothorax 9.8
364 dysostosis 9.8
365 neuroma 9.8
366 pancreas disease 9.8
367 ascaridiasis 9.8
368 lung squamous cell carcinoma 9.8
369 eosinophilic gastroenteritis 9.8
370 pancreatic adenocarcinoma 9.8
371 bile duct adenoma 9.8
372 hypereosinophilic syndrome 9.8
373 mirizzi syndrome 9.8
374 back pain 9.8
375 encephalopathy 9.8
376 overgrowth syndrome 9.8
377 tuberculous peritonitis 9.8 CRP CEACAM5 ALB
378 acute pyelonephritis 9.8 IL6 GPT CRP CALCA ALB
379 pyelonephritis 9.8 IL6 GPT CRP CALCA ALB
380 gastrointestinal tuberculosis 9.8 CRP CEACAM5 ALB
381 duodenal obstruction 9.8 CRP CEACAM5 ALB
382 appendix disease 9.8 MUC5AC CEACAM5
383 mineral metabolism disease 9.8 IL6 GPT CRP CALCA ALB
384 lymphangitis 9.8 CRP CEACAM5 ALB
385 bile duct rhabdomyosarcoma 9.7 GGTLC3 GGT2 GGT1
386 hyperthyroidism 9.7 IL6 GPT CRP CALCA ALB
387 splenic tuberculosis 9.7 GGTLC3 GGT2 GGT1
388 perforation of bile duct 9.7 GGTLC3 GGT2 GGT1
389 diabetes mellitus, type i 9.7 IL6 IL1RN CRP ALB
390 dysentery 9.7 IL6 IL1RAPL2 GPT CRP ALB
391 duodenum adenocarcinoma 9.7 MUC5AC CEACAM5
392 optic nerve astrocytoma 9.7 GGTLC3 GGT2 GGT1
393 myasthenic syndrome, congenital, 3b, fast-channel 9.7 GGTLC3 GGT2 GGT1
394 dientamoebiasis 9.7 GGTLC3 GGT2 GGT1
395 peripheral nervous system disease 9.7 IL6 GPT CRP CALCA ALB
396 glutathionuria 9.7 GGTLC3 GGT2 GGT1
397 heart aneurysm 9.7 IL6 IL1RN GPT CRP ALB
398 coronary aneurysm 9.7 IL6 IL1RN GPT CRP ALB
399 pharyngitis 9.7 IL6 IL1RN GPT CRP ALB
400 noonan syndrome 8 9.7 GGTLC3 GGT2 GGT1
401 amelogenesis imperfecta, type if 9.7 GGTLC3 GGT2 GGT1
402 nephrolithiasis 9.7 IL1RN GGT1 F2 ALB
403 familial adenomatous polyposis 2 9.7 GGTLC3 GGT2 GGT1
404 giant axonal neuropathy 1, autosomal recessive 9.7 GGTLC3 GGT2 GGT1
405 cataract 34, multiple types 9.7 GGTLC3 GGT2 GGT1
406 pulmonary disease, chronic obstructive 9.7 MUC5AC IL6 CRP ALB
407 cardiovascular system disease 9.7 IL6 GGT1 CRP ALB
408 loeys-dietz syndrome 2 9.7 GGTLC3 GGT2 GGT1
409 loeys-dietz syndrome 9.7 GGTLC3 GGT2 GGT1
410 gastric diffuse adenocarcinoma 9.7 MUC5AC CEACAM5
411 cataract 4, multiple types 9.7 GGTLC3 GGT2 GGT1
412 contractural arachnodactyly, congenital 9.7 GGTLC3 GGT2 GGT1
413 neutropenia 9.7 IL6 IL1RN GPT CRP ALB
414 cholestasis, progressive familial intrahepatic, 1 9.7 GGTLC3 GGT2 GGT1
415 migraine with or without aura 1 9.7 IL6 F2 CRP CALCA ALB
416 appendix cancer 9.7 MUC5AC CEACAM5
417 granulomatous hepatitis 9.7 GPT GGTLC3 CRP ALB
418 pyuria 9.7 IL6 GPT F2 CRP ALB
419 compartment syndrome 9.7 IL6 GPT F2 CRP ALB
420 aspiration pneumonia 9.7 IL6 GPT F2 CRP ALB
421 behcet syndrome 9.7 IL6 IL1RN F2 CRP ALB
422 plasma protein metabolism disease 9.7 IL6 GPT F2 CRP ALB
423 pulmonary artery disease 9.7 IL6 GPT F2 CRP ALB
424 splenic disease 9.7 IL6 GPT F2 CRP ALB
425 pulmonary hypertension 9.7 IL6 F2 CRP CALCA ALB
426 syphilis 9.7 IL6 GPT F2 CRP ALB
427 autoimmune disease of gastrointestinal tract 9.7 IL6 GPT F2 CRP ALB
428 blood coagulation disease 9.7 IL6 GPT F2 CRP ALB
429 blood platelet disease 9.7 IL6 GPT F2 CRP ALB
430 ovarian mucinous adenocarcinoma 9.7 MUC5AC CEACAM5
431 familial hypercholesterolemia 9.7 IL6 GPT F2 CRP ALB
432 protein-energy malnutrition 9.7 IL6 IL1RAPL2 GPT GGT1 ALB
433 mucoepidermoid carcinoma 9.6 MUC5AC CEACAM5 CALCA
434 pre-eclampsia 9.6 IL6 GPT F2 CRP ALB
435 hypothyroidism 9.6 GPT F2 CRP CALCA ALB
436 autoimmune hepatitis 9.6 IL6 GPT GGT1 F2 ALB
437 conjunctival disease 9.6 MUC5AC IL6 IL1RN CRP ALB
438 rectal disease 9.6 IL6 CRP CEACAM5 ALB
439 non-alcoholic fatty liver disease 9.6 IL6 GPT GGT1 CRP ALB
440 hepatitis b 9.6 IL6 GPT GGT1 F2 ALB
441 primary biliary cirrhosis 9.6 IL6 GPT GGT1 F2 ALB
442 pulmonary fibrosis, idiopathic 9.5 MUC5AC IL6 IL1RN CRP ALB
443 algoneurodystrophy 9.5 GGTLC3 GGT2 GGT1 CALCA
444 osteoporosis 9.5 IL6 IL1RN IL1RAPL2 CRP CALCA ALB
445 hemorrhoid 9.5 F2 CRP CEACAM5 ALB
446 hepatoid adenocarcinoma 9.5 CEACAM5 ALB
447 pericardium disease 9.5 IL6 IL1RN GPT F2 CRP ALB
448 pericardial effusion 9.5 IL6 IL1RN GPT F2 CRP ALB
449 exanthem 9.5 IL6 IL1RN GPT F2 CRP ALB
450 lipoprotein quantitative trait locus 9.4 IL6 IL1RN GPT F2 CRP ALB
451 bile acid synthesis defect, congenital, 1 9.4 GGTLC3 GGT2 GGT1 ALB
452 constipation 9.4 IL6 GPT GGT1 CRP CALCA ALB
453 distal arthrogryposis 9.4 GGTLC3 GGT2 GGT1 ALB
454 myocardial infarction 9.4 IL6 IL1RN GPT F2 CRP ALB
455 cataract 9.4 IL6 IL1RN GPT GGT1 CRP ALB
456 heart disease 9.3 IL6 IL1RN GPT F2 CRP ALB
457 otitis media 9.3 MUC5AC IL6 IL1RN GPT CRP ALB
458 intestinal obstruction 9.3 IL6 GPT CRP CEACAM5 ALB
459 typhoid fever 9.3 IL6 GPT GGT1 F2 CRP ALB
460 alcoholic hepatitis 9.3 IL6 GPT GGT1 F2 CRP ALB
461 viral hepatitis 9.3 IL6 GPT GGT1 F2 CRP ALB
462 inherited metabolic disorder 9.3 IL6 GPT GGT1 F2 CRP ALB
463 pleural disease 9.3 IL6 F2 CRP CEACAM5 ALB
464 pneumonia 9.3 TREM1 IL6 IL1RN GPT F2 CRP
465 viral laryngitis 9.3 GPT GGTLC3 GGT2 GGT1 CRP
466 lens disease 9.2 IL6 GGTLC3 GGT2 GGT1 ALB
467 abdominal tuberculosis 9.2 GPT F2 CRP CEACAM5 ALB
468 asthma 9.2 MUC5AC IL6 IL1RN F2 CALCA ALB
469 alcohol use disorder 9.2 GPT GGTLC3 GGT2 GGT1 ALB
470 lung disease 9.1 MUC5AC IL6 CRP CEACAM5 ALB
471 thyroid gland disease 9.1 IL6 GPT CRP CEACAM5 CALCA ALB
472 gallbladder papillary carcinoma 9.1 GGTLC3 GGT2 GGT1 CEACAM5
473 cecal disease 9.1 IL6 GPT F2 CRP CEACAM5 ALB
474 deficiency anemia 9.0 IL6 GGTLC3 GGT2 GGT1 CRP ALB
475 esophageal varix 8.9 GPT GGTLC3 GGT2 GGT1 F2 ALB
476 malaria 8.9 TREM1 IL6 IL1RN GPT GGT1 F2
477 diabetes mellitus 8.9 IL6 IL1RN GPT GGT1 F2 CRP
478 immature teratoma of ovary 8.9 GGTLC3 GGT2 GGT1 F2 CEACAM5
479 eye disease 8.8 IL6 IL1RN GGTLC3 GGT2 GGT1 CRP
480 lipid storage disease 8.8 IL6 GPT GGTLC3 GGT2 GGT1 CRP
481 cholangitis, primary sclerosing 8.7 IL6 GPT GGTLC3 GGT2 GGT1 F2
482 diabetes mellitus, noninsulin-dependent 8.7 IL6 GPT GGTLC3 GGT2 GGT1 CRP
483 inflammatory bowel disease 8.7 TREM1 MUC5AC IL6 IL1RN IL1RAPL2 F2
484 vein disease 8.5 IL6 GPT GGTLC3 GGT2 GGT1 F2
485 hepatic vascular disease 8.5 IL6 GPT GGTLC3 GGT2 GGT1 F2
486 hypertension, essential 8.3 IL6 GPT GGTLC3 GGT2 GGT1 F2
487 common bile duct disease 8.0 GPT GGTLC3 GGT2 GGT1 F2 CRP
488 bile duct disease 7.9 IL6 GPT GGTLC3 GGT2 GGT1 F2

Graphical network of the top 20 diseases related to Acute Cholangitis:



Diseases related to Acute Cholangitis

Symptoms & Phenotypes for Acute Cholangitis

Drugs & Therapeutics for Acute Cholangitis

Drugs for Acute Cholangitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 19, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Anti-Bacterial Agents Phase 4
2 Antibiotics, Antitubercular Phase 4
3
Sage Approved
4
Fentanyl Approved, Illicit, Investigational, Vet_approved 437-38-7 3345
5
Lidocaine Approved, Vet_approved 137-58-6 3676
6
Sodium citrate Approved, Investigational 68-04-2
7
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
8
Rocuronium Approved 119302-91-9, 143558-00-3 441290
9
Sevoflurane Approved, Vet_approved 28523-86-6 5206
10
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
11
Indomethacin Approved, Investigational 53-86-1 3715
12
Citric acid Approved, Nutraceutical, Vet_approved 77-92-9 311
13 Antitubercular Agents
14 Tea
15 Citrate
16 Anesthetics
17 Hemostatics
18 Coagulants
19 Anti-Infective Agents

Interventional clinical trials:

(showing 21, show less)
# Name Status NCT ID Phase Drugs
1 Albumin Administration in the Prevention of Hepatorenal Syndrome and Death in Patients With Cirrhosis, Bacterial Infections Other Than Spontaneous Bacterial Peritonitis and High Risk of Hospital Mortality Terminated NCT02034279 Phase 4 Albumin
2 Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy Sub-Study Completed NCT02070627 Phase 1 Indocyanine Green (ICG)
3 The Necessity of Bile Cultures in Patients With Acute Cholangitis Unknown status NCT02601417
4 The Assessment of Awareness and Implementation of the SAGES Safe Cholecystectomy Program Among Polish Surgeons, as Well as Their Opinion on the Usefulness of the SAGES Safe Cholecystectomy Rules: Increasing the Safety of Cholecystectomy by Popularising the SAGES Safe Cholecystectomy Program Unknown status NCT03155321
5 Prospective Randomized Study Comparing the Effects of Endoscopic Sphincterotomy (EST) and Endoscopic Papillary Balloon Dilation (EPBD) in Patients With Acute Biliary Pancreatitis (ABP) Unknown status NCT02668081
6 Radiofrequency Ablation Plus Stenting Versus Stenting Alone for Treatment of Malignant Biliary Obstruction Unknown status NCT03166436
7 Prognostic Factors Associated With Mortality Within 6 Months Among Critically Ill Elderly Patients Admitted to the Intensive Care Unit With Severe Acute Cholangitis Completed NCT03831529
8 An Open-labeled, Randomized Controlled Trial Comparing Between Short Duration And Standard Fourteen Days Antibiotic Treatments In Patients With Acute Common Bile Duct Stone Cholangitis After Successful Endoscopic Biliary Drainage Completed NCT03422042
9 Cytological Evaluation of Biliary Epithelium After Previous Endoscopic Sphincterotomy for Benign Disease Completed NCT01135732
10 A Randomized Trial to Identify the Optimal Approach for Management of Difficult Bile Duct Stones Completed NCT00852072
11 A Prospective Randomized Trial Comparing EUS Guided ERCP Without Fluoroscopy With Standard ERCP in Common Bile Duct Stone Removal Completed NCT02870686
12 Comparison of Bi-spectral Index-Controlled Sedation During a Thoracic Epidural Anesthesia With General Anesthesia in Laparoscopic Cholecystectomy Completed NCT03107832
13 Common Bile Duct Stone Management: What Have we Learned? Completed NCT02155244
14 Laparoscopic Cholecystectomy is no More Risky in Emergent Cases With in Cardiopulmonary Risk: Fundus-Callot Cholecystectomy With Low Pressure Pneumo-peritoneum VS Open Cholecystectomy - Randomized Controlled Trials Completed NCT04373447
15 Division of Hepato-gastroenterology; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,Taiwan Recruiting NCT03754491
16 Is Short Antibiotherapy Duration After Drainage Suitable for Patients Admitted in Intensive Care Medicine With a Severe Acute Cholangitis? Recruiting NCT04173286
17 The Clinical Evaluation of Oddi Spincteroplasty With Blood Vessel Clamp After Iatrogenic Injury by ERCP Recruiting NCT03795584
18 Randomized Multicentre Double-blind Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage in Non-surgical Patients With Symptomatic Choledocholithiasis Recruiting NCT03921502
19 Endoscopic Sphincterotomy (EST) for Bile Duct Gallstones Cause Damage to the Ampulla of Vater and Sphincter of Oddi (SO): Endoclip Papillaplasty Help Recover the Damaged SO Function and Possibly Prevent Gallstone Recurrence Recruiting NCT04183036
20 Microbial Profile of Cholangitis in Patients Undergoing Biliary Intervention Not yet recruiting NCT04216745
21 A Comparison of Results With Bile and Blood Culture in Patients With Acute Cholangitis According to Severity Terminated NCT02107560

Search NIH Clinical Center for Acute Cholangitis

Genetic Tests for Acute Cholangitis

Anatomical Context for Acute Cholangitis

MalaCards organs/tissues related to Acute Cholangitis:

40
Liver, Pancreas, Lung, T Cells, Thymus, Heart, Colon

Publications for Acute Cholangitis

Articles related to Acute Cholangitis:

(showing 1005, show less)
# Title Authors PMID Year
1
Outcomes following early versus delayed cholecystectomy performed for acute cholangitis. 61
31482348 2020
2
A different kind of acute cholangitis: Subacute Ikeda type II peripapillary choledochoduodenal fistula? 61
32409178 2020
3
A rare case of acute cholangitis after endoscopic ampullectomy. 61
32450700 2020
4
Post-endoscopic retrograde cholangiopancreatography pancreatitis in single-stage endoscopic common bile duct stone removal. 61
32514443 2020
5
Response to: Approach to evaluation of choledocholithiasis in patient with or without acute cholangitis. 61
32125414 2020
6
Application and Value of Endoscopic Ultrasonography Guided Biliary Interventional Therapy in Patients With Biliary Obstruction and Surgically Altered Anatomy. 61
32487860 2020
7
Prevalence, resistance-rates and risk-factors of pathogens in routine bile cultures obtained during endoscopic retrograde cholangiography. 61
32521535 2020
8
Troubleshooting for severe acute cholangitis caused by proximally migrated metal stent into the intrahepatic bile duct: Stent shortening via a balloon catheter. 61
32472625 2020
9
Hepatectomy and intrahepatic hepaticocutaneous jejunostomy for bilateral primary hepatolithiasis: Case report. 61
32512411 2020
10
Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: A single-center retrospective cohort study. 61
32376307 2020
11
Utilization of a new technology of 3D biliary CT for ERCP-related procedures: a case report. 61
32448154 2020
12
[Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis]. 61
32448856 2020
13
Diagnostic inflammatory markers of acute cholangitis in liver transplant recipients. 61
32378775 2020
14
Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis. 61
32213042 2020
15
ERCP for acute cholangitis: timing is everything. 61
32204811 2020
16
Diagnostic performance of 64-MDCT in detecting ERCP-proven periampullary duodenal diverticula. 61
31893332 2020
17
Early malfunction of a biliary self-expandable metal stent with an antireflux valve: A case report. 61
32311973 2020
18
Management of portal cavernoma-associated cholangiopathy: Single-centre experience. 61
31255533 2020
19
Microbiology and clinical characteristics of acute cholangitis with their impact on mortality; a retrospective cross sectional study. 61
32296203 2020
20
The Impact of Laparoscopic Cholecystectomy on 30-Day Readmission Rate for Acute Cholangitis Patients: A Single-Center Study. 61
32248392 2020
21
Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. 61
31628955 2020
22
Rethinking fibrinogen storage disease of the liver: ground glass and globular inclusions do not represent a congenital metabolic disorder but acquired collective retention of proteins. 61
32330484 2020
23
Disparities in bile duct injury care. 61
31190224 2020
24
Risk factors for adverse events associated with bile leak during EUS-guided hepaticogastrostomy. 61
32295968 2020
25
Inside Plastic Stents versus Metal Stents for Treating Unresectable Malignant Perihilar Biliary Obstructions: A Retrospective Comparative Study. 61
32126740 2020
26
Safety and efficacy of emergency laparoscopic common bile duct exploration in elderly patients with complicated acute cholangitis. 61
31209606 2020
27
Timing of Performing Endoscopic Retrograde Cholangiopancreatography and Inpatient Mortality in Acute Cholangitis: A Systematic Review and Meta-Analysis. 61
32352721 2020
28
A novel integrated inside biliary stent and nasobiliary drainage catheter system for biliary drainage (with video). 61
31654477 2020
29
[Gallstone disease - interdisciplinary treatment]. 61
32120403 2020
30
Endoscopic Self-Expandable Metal Stent Placement for Malignant Afferent Loop Obstruction After Pancreaticoduodenectomy: A Case Series and Review. 61
32124582 2020
31
Active bleeding due to a hepatic arterial pseudoaneurysm that occurred after acute cholangitis. 61
32054281 2020
32
Emergent Treatment of Acute Cholangitis and Acute Cholecystitis. 61
32139966 2020
33
Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis. 61
32164573 2020
34
Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis. 61
32050314 2020
35
Rapid formation of large pseudostones and acute cholangitis caused by ceftriaxone treatment for bacterial pneumonia in a patient on kidney transplantation: potential risk of ceftriaxone use in patients with decreased kidney function. 61
31531767 2020
36
Quantification of metronidazole in human bile fluid and plasma by liquid chromatography-tandem mass spectrometry. 61
31911204 2020
37
Signet-ring cell carcinoma of the ampulla of Vater: a case diagnosed via repeated biopsies. 61
31981088 2020
38
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Introduced by Biliary Stents or Local Immersion in Porcine Bile Duct Anastomoses. 61
31742878 2020
39
Management of afferent loop syndrome after Roux-en-Y subtotal gastrectomy and choledocolithiasis with recurrent cholangitis. 61
31907217 2020
40
Increasing burden of biliary tract infection caused by extended-spectrum beta-lactamase-producing organisms in Korea: A nationwide population-based study. 61
31359494 2020
41
Shortening antibiotic duration in the treatment of acute cholangitis: rationale and study protocol for an open-label randomized controlled trial. 61
31952554 2020
42
A nomogram for predicting the risk of sepsis in patients with acute cholangitis. 61
31429338 2020
43
Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis. 61
32508526 2020
44
ERCP for severe acute cholangitis: The earlier, the better. 61
32009619 2020
45
Life-threatening duodenal perforation complicating endoscopic retrograde cholangiopanceatography: A case series. 61
31978721 2020
46
Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database. 61
31950275 2020
47
Clinical Efficacy Analysis of the Combination of the Laparoscope and Preoperative or Intraoperative Duodenoscope in the Treatment of Cholecystolithiasis with Choledocholithiasis: A Retrospective Study. 61
31647359 2019
48
Laparoscopic cholecystectomy after endoscopic treatment of choledocholithiasis: a retrospective comparative study. 61
30644060 2019
49
The risk of acute cholangitis after endoscopic stenting for malignant hilar strictures: A large comprehensive study. 61
31802535 2019
50
Management of liver hydatid cyst with cystobiliary communication and acute cholangitis: a 27-year experience. 61
30191292 2019
51
Acute cholangitis: Diagnosis and management. 61
31248783 2019
52
Does measurement of the hepatic artery velocity improve the sonographic diagnosis of cholangitis? 61
31673717 2019
53
Von Meyenburg Complexes Found Incidentally in a Patient With Acute Cholangitis. 61
29857154 2019
54
Screening acute cholangitis patients for sepsis. 61
31566288 2019
55
Epidemiological profile, referral routes and diagnostic accuracy of cases of acute cholangitis among individuals with obstructive jaundice admitted to a tertiary-level university hospital: a cross-sectional study. 61
32159634 2019
56
Validity and safety of endoscopic biliary stenting for biliary stricture associated with IgG4-related pancreatobiliary disease during steroid therapy. 61
31673612 2019
57
The efficacy and safety of one-stage endoscopic treatment for ascending acute cholangitis caused by choledocholithiasis with severe comorbidities. 61
31586253 2019
58
Pharmacokinetic-pharmacodynamic comparison of ceftriaxone regimens in acute cholangitis. 61
31130393 2019
59
A study of primary single and layered suture technique by using two-port laparoscopic choledocholithotomy. 61
29974880 2019
60
Review of the Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis. 61
31268508 2019
61
Efficacy and safety of endoscopic retrograde cholangiopancreatography in pregnancy: A high-volume study with long-term follow-up. 61
31258133 2019
62
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review. 61
30922600 2019
63
Antrodia Cinnamomea Prolongs Survival in a Patient with Small Cell Lung Cancer. 61
31561410 2019
64
Timing of Cholecystectomy after Emergent Endoscopic Retrograde Cholangiopancreatography for Cholangitis. 61
31560309 2019
65
[Secondary cholangitis of the critically ill]. 61
31398769 2019
66
Traumatic bile duct neuroma presenting with acute cholangitis: A case report and review of literature. 61
31501819 2019
67
Common bile duct stone development due to a Hem-o-lok clip migration: a rare complication of laparoscopic cholecystectomy. 61
31352393 2019
68
Clinicopathological findings and imaging features of intraductal papillary neoplasm of the bile duct: comparison between contrast-enhanced ultrasound and contrast-enhanced computed tomography. 61
31093728 2019
69
Mini-invasive interventions in acute cholangitis malignant and benign etiology. 61
32085280 2019
70
Gallbladder Perforation Due to Ascaris lumbricoides in a Pregnant Woman and 6 Year Old Girl from Afghanistan: Case Report. 61
31673268 2019
71
Utility of Endoscopic Retrograde Cholangiopancreatography in the Treatment of Intraductal Papillary Neoplasm of the Bile Duct. 61
31620522 2019
72
Diverticulum of common hepatic duct leading to obstructive jaundice, a case report. 61
31501706 2019
73
The Feasibility of Conventional Forward-viewing Endoscope for Endoscopic Retrograde Cholangiopancreatography in Patients With Altered Gastrointestinal Anatomy. 61
30720694 2019
74
Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones: a multicentre, single-blinded, randomised controlled trial. 61
31003961 2019
75
Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. 61
30943551 2019
76
ACR Appropriateness Criteria® Radiologic Management of Biliary Obstruction. 61
31054746 2019
77
Acute Cholangitis with Atypical Clinical Presentation and Imaging. 61
30392151 2019
78
Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study. 61
30600674 2019
79
Late hepaticartery thrombosis after liver transplantation: which strategy? A single-center retrospective study. 61
30582255 2019
80
Upper gastrointestinal hemorrhage is associated with poor outcomes among patients with acute cholangitis: a nationwide analysis. 61
30741727 2019
81
Cholangitis: Causes, Diagnosis, and Management. 61
30846028 2019
82
Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation. 61
30449812 2019
83
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Acute Cholangitis: The Sooner, the Better. 61
28697150 2019
84
[Comparison of the minimally invasive treatments of laparoscopic and endosopic for common bile duct stones after gastrojejunostomy]. 61
30996380 2019
85
[Operative method choice and strategy of laparoscopic surgery therapy for gallbladder stones and common bile duct stones]. 61
30929374 2019
86
A rare cause of abdominal pain with fever. 61
30878967 2019
87
Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use. 61
30505677 2019
88
Unchanged mortality in patients with acute cholangitis despite an increase in malignant etiologies - a 25-year epidemiological study. 61
30946608 2019
89
Short-Course Antibiotic Treatment Is Not Inferior to a Long-Course One in Acute Cholangitis: A Systematic Review. 61
30368681 2019
90
Efficacy and safety of early cholecystectomy for comorbid acute cholecystitis and acute cholangitis: Retrospective cohort study. 61
30581570 2019
91
Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature. 61
30755259 2019
92
Management of Acute Gallstone Cholangitis after Roux-en-Y Gastric Bypass with Laparoscopic Transgastric Endoscopic Retrograde Cholangiopancreatography. 61
30539515 2019
93
Is endoscopic sphincterotomy beneficial for the treatment of acute gallstone pancreatitis with small bile duct stone? 61
30576296 2019
94
Massive hemobilia following plastic stent removal in common bile duct cancer associated with primary sclerosing cholangitis (with video). 61
30056613 2019
95
[Massive biliary hemorrhage due to rupture of pseudoaneurysm after endoscopic biliary plastic stenting for pancreatic cancer]. 61
31511462 2019
96
Early vs late endoscopic retrograde cholangiopancreatography in patients with acute cholangitis: A nationwide analysis. 61
30705731 2019
97
Single-Stage Endoscopic Stone Extraction and Cholecystectomy during the Same Hospitalization. 61
30300983 2019
98
A Duplicated Gallbladder in a Patient Presenting with Acute Cholangitis. A Case Study and a Literature Review. 61
31113599 2019
99
Acute cholangitis secondary to hydatid membranes in the biliary tract. 61
30176226 2019
100
Endoscopic Retrograde Cholangio-Pancreatography-Obtained Bile Culture Can Guide Antibiotic Therapy in Acute Cholangitis. 61
30282078 2019
101
The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature. 61
30775241 2019
102
A Simple Method for Measuring Adenosine Triphosphate in Acute Cholangitis Patients to Determine the Need for Emergency Biliary Drainage. 61
31735735 2019
103
Percutaneous Transcholecystic Removal of Common Bile Duct Stones: Case Series in 114 Patients. 61
30226454 2019
104
Natural killer T cells mediate inflammation in the bile ducts. 61
30115993 2018
105
Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. 61
29408612 2018
106
Same-admission versus delayed cholecystectomy for mild acute biliary pancreatitis: a systematic review and meta-analysis. 61
30486807 2018
107
Successful emergency endoscopic drainage for afferent limb syndrome-induced severe acute cholangitis in a patient with altered Roux-en Y anatomy. 61
30039511 2018
108
Outcomes Associated With Timing of ERCP in Acute Cholangitis Secondary to Choledocholithiasis. 61
29356786 2018
109
Diagnostic value of elevated serum carbohydrate antigen 199 level in acute cholangitis secondary to choledocholithiasis. 61
30294608 2018
110
Long term outcome of EUS-based strategy for suspected choledocholithiasis but negative CT finding. 61
30516401 2018
111
Procalcitonin as a Decision-Supporting Marker of Urgent Biliary Decompression in Acute Cholangitis. 61
29480416 2018
112
Management of acute pancreatitis in the first 72 hours. 61
29957661 2018
113
Tumor recurrence after liver transplantation for diffuse biliary papillomatosis in the absence of invasive carcinoma. 61
29938516 2018
114
Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies. 61
30041279 2018
115
Acute cholangitis complicating a chronic alveolar echinococcosis: an unusual therapeutic cholangioscopy. 61
29895060 2018
116
Diagnostic inflammatory markers in acute cholangitis. 61
29907228 2018
117
2-year follow-up of Lung transplantation as a treatment of Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) - a case report. 61
30110120 2018
118
Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis. 61
29699063 2018
119
A study of a pancreatic mass: not all is what it seems. 61
29900747 2018
120
No Association of Timing of Endoscopic Biliary Drainage with Clinical Outcomes in Patients with Non-severe Acute Cholangitis. 61
29663264 2018
121
Endoscopic ultrasound-guided choledochoduodenostomy using a lumen apposing metal stent for acute cholangitis. 61
30249569 2018
122
Gastrointestinal: Unusual cause of acute cholangitis in a chronic pancreatitis patient. 61
29607537 2018
123
Re: Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. 61
29878694 2018
124
Response to Re: Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. 61
29878697 2018
125
ERCP performed through previously placed duodenal stents: a multicenter retrospective study of outcomes and adverse events. 61
29425886 2018
126
Pantoprazole-induced autoimmune chronic hepatitis. 61
29532602 2018
127
Giant choledochal cyst presenting during third trimester of pregnancy. 61
29898912 2018
128
Percutaneous cholecystostomy for high-risk patients with acute cholangitis. 61
29742738 2018
129
[Timing of endoscopic retrograde cholangiopancreatography in patients with acute cholangitis]. 61
30348251 2018
130
Endoscopic Ultrasound-Guided Choledochoduodenostomy as Palliative Treatment: A Challenging Case Report. 61
29761151 2018
131
Temporal trends in utilization and outcomes of endoscopic retrograde cholangiopancreatography in acute cholangitis due to choledocholithiasis from 1998 to 2012. 61
28917018 2018
132
Early Endoscopic Retrograde Cholangiopancreatography Versus Conservative Treatment in Patients With Acute Biliary Pancreatitis: Systematic Review and Meta-analysis of Randomized Controlled Trials. 61
29517637 2018
133
How SpyGlass™ May Impact Endoscopic Retrograde Cholangiopancreatography Practice and Patient Management. 61
29761149 2018
134
Clinical applicability of Tokyo guidelines 2018/2013 in diagnosis and severity evaluation of acute cholangitis and determination of a new severity model. 61
29374984 2018
135
Acute cholangitis - an update. 61
29487761 2018
136
Predicting Efficacy of Plastic Stents for Posttransplantation Biliary Strictures. 61
27775958 2018
137
Worsening of Acute Cholangitis Caused by a Bile Duct Stone After Hospitalization: A Case Series. 61
29511408 2018
138
Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis. 61
28628948 2018
139
Inflammatory and Ischemic Post Liver Transplant Complications Mimic Malignancy on 18F-FDG PET/CT. 61
29393053 2018
140
Association between early ERCP and mortality in patients with acute cholangitis. 61
28433613 2018
141
Early biliary drainage is associated with favourable outcomes in critically-ill patients with acute cholangitis. 61
29657606 2018
142
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). 61
29032610 2018
143
Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. 61
28941329 2018
144
Tokyo Guidelines 2018: updated Tokyo Guidelines for the management of acute cholangitis/acute cholecystitis. 61
29334699 2018
145
Endoscopic diagnosis and treatment of biliary obstruction due to acute cholangitis and acute pancreatitis secondary to Fasciola hepatica infection. 61
29350372 2018
146
Assessing methodological quality of Russian clinical practice guidelines and introducing AGREE II instrument in Russia. 61
30204760 2018
147
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). 61
29032636 2018
148
The Emergency Medicine-Focused Review of Cholangitis. 61
28939398 2018
149
[A case of a hepatic arterial pseudoaneurysm that occurred after acute cholangitis due to choledocholithiasis]. 61
30197395 2018
150
Management of endoscopic biliary stenting for choledocholithiasis: Evaluation of stent-exchange intervals. 61
29375741 2018
151
Efficacy and Safety of Single-Session Endoscopic Stone Removal for Acute Cholangitis Associated with Choledocholithiasis. 61
30175087 2018
152
Bedside Endoscopic Retrograde Cholangiopancreatography Using Portable X-Ray in Acute Severe Cholangitis. 61
29682365 2018
153
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. 61
29090866 2018
154
Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. 61
29090868 2018
155
Re: Acute cholangitis: current concepts. 61
29392900 2018
156
Acquired Leukocyte Inclusion Bodies Resembling Döhle Bodies During Acute Cholangitis. 61
28747290 2017
157
Obstruction of the Biliary and Urinary System. 61
29224663 2017
158
Cholangitis: Diagnosis, Treatment and Prognosis. 61
29226107 2017
159
A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia. 61
29245350 2017
160
Candida Tropicalis Cholangitis in a Patient Without Underlying Malignancy. 61
29375953 2017
161
[A Case Report of Long-Term Survival after Excision for Needle Tract Implantation of Biopsy and Hepatectomy for Cholangiocarcinoma with Gall Bladder Hemorrhage]. 61
29394711 2017
162
[A Case of Urothelial Carcinoma Who Underwent Pancreaticoduodenectomy and Was Diagnosed with Groove Pancreatitis and Preoperatively Suffered from Duodenal Stenosis]. 61
29394848 2017
163
Comparable Long-term Outcomes of 1-Minute vs 5-Minute Endoscopic Papillary Balloon Dilation for Bile Duct Stones. 61
28603054 2017
164
Case Report: Biliary Pancreatitis With Acute Cholangitis in a Patient Under Anticoagulant Treatment With Dabigatran. 61
29075173 2017
165
Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. 61
28254686 2017
166
Acute Cholangitis After Bilioenteric Anastomosis for Bile Duct Injuries. 61
28744740 2017
167
Cholecystoduodenal fistula, an infrequent complication of cholelithiasis: Our experience in its surgical management. 61
28389051 2017
168
Evaluation and Comparison of Charcot's Triad and Tokyo Guidelines for the Diagnosis of Acute Cholangitis. 61
29089703 2017
169
Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. 61
28834389 2017
170
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer. 61
28317087 2017
171
Intraductal papillary neoplasia of the bile duct with malignancy: a differentiated entity of cholangiocarcinoma with a better prognosis. A review of three new cases. 61
28617032 2017
172
Preoperative biliary drainage versus direct surgery for perihilar cholangiocarcinoma: A retrospective study at a single center. 61
28529266 2017
173
Endoscopic Papillary Large Balloon Dilation Versus Endoscopic Sphincterotomy for Retrieval of Large Choledocholithiasis: A Prospective Randomized Trial. 61
28402704 2017
174
Optimal Timing of Endoscopic Retrograde Cholangiopancreatography in Acute Cholangitis. 61
27875357 2017
175
Acute cholangitis: current concepts. 61
28337833 2017
176
Feasibility of initial endoscopic common bile duct stone removal in patients with acute cholangitis. 61
28798923 2017
177
Cholangitis after endoscopic retrograde cholangiopancreatography: a rare complication? 61
28593787 2017
178
Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. 61
27783206 2017
179
Comparison of acute cholangitis with or without common bile duct dilatation. 61
28587432 2017
180
Bacteremia with Raoultella planticola in the setting of acute pancreatitis complicated with acute cholangitis. 61
28229615 2017
181
Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study. 61
28419764 2017
182
Single-operator cholangioscopy for biliary complications in liver transplant recipients. 61
28652659 2017
183
Initial Report of Outpatient Management of Acute Cholangitis via ERCP. 61
28315026 2017
184
Comparative performance of non-contrast MRI with HASTE vs. contrast-enhanced MRI/3D-MRCP for possible choledocholithiasis in hospitalized patients. 61
28154911 2017
185
Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. 61
28371094 2017
186
Abdominal ultrasonography for patients with abdominal pain as a first-line diagnostic imaging modality. 61
28565789 2017
187
The rendezvous technique involving insertion of a guidewire in a percutaneous transhepatic gallbladder drainage tube for biliary access in a case of difficult biliary cannulation. 61
28593017 2017
188
Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis. 61
31153445 2017
189
Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis. 61
28425414 2017
190
Endoscopic management of acute cholangitis as a result of common bile duct stones. 61
28425658 2017
191
Current strategies for endoscopic management of acute cholangitis. 61
28425650 2017
192
Endoscopic management of acute cholangitis according to the TG13. 61
28425666 2017
193
Diagnostic accuracy of Charcot's triad: a systematic review. 61
28213923 2017
194
Is addition of endoscopic sphincterotomy before endoscopic biliary drainage necessary for acute cholangitis as a result of common bile duct stones? 61
28425654 2017
195
Management of acute cholangitis as a result of occlusion from a self-expandable metallic stent in patients with malignant distal and hilar biliary obstructions. 61
28425663 2017
196
Can endoscopic stone retraction be carried out even in cases with severe acute cholangitis? 61
28425647 2017
197
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis. 61
27357988 2017
198
Catheterization of the gallbladder: A novel mouse model of severe acute cholangitis. 61
28348482 2017
199
Usefulness of the Delta Neutrophil Index as a Promising Prognostic Marker of Acute Cholangitis in Emergency Departments. 61
27559701 2017
200
Aortic and splanchnic artery aneurysms: Unusual causes of biliary obstruction - A retrospective cohort from literature. 61
28153785 2017
201
Small Gallstone Size and Delayed Cholecystectomy Increase the Risk of Recurrent Pancreatobiliary Complications After Resolved Acute Biliary Pancreatitis. 61
28035552 2017
202
Listeria monocytogenes meningitis preceded by acute cholangitis. 61
28320704 2017
203
IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis. 61
28002647 2017
204
Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. 61
28027992 2017
205
Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis: a meta-analysis. 61
28229129 2017
206
Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. 61
28076388 2017
207
Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. 61
28192501 2017
208
Endoscopic-ultrasonography-guided biliary drainage for repetitive acute cholangitis of the accessory hepatic duct obstructed by clipping during laparoscopic cholecystectomy. 61
28381783 2017
209
Percutaneous Endoscopic Management for Oriental Cholangiohepatitis: A Case Report and a Brief Review of the Literature. 61
28932607 2017
210
Usefulness of Endoscopic Managements in Patients with Ceftriaxone-Induced Pseudolithiasis Causing Biliary Obstruction. 61
29230246 2017
211
Complications and management of forgotten long-term biliary stents. 61
28216968 2017
212
Internal transfistulary drainage for intrabiliary rupture of hydatid cyst of the liver: Analysis of the indications and the results. Report of 50 cases. 61
29327763 2017
213
The First Case Report of Acute Cholangitis and Bacteremia Due to Neisseria subflava. 61
28090057 2017
214
Use of 4-Fr versus 6-Fr Nasobiliary Catheter for Biliary Drainage: A Prospective, Multicenter, Randomized, Controlled Study. 61
28503061 2017
215
Efficacy of multiple biliary stenting for refractory benign biliary strictures due to chronic calcifying pancreatitis. 61
28101303 2017
216
Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study. 61
28086796 2017
217
Urgent ERCP for acute cholangitis reduces mortality and hospital stay in elderly and very elderly patients. 61
27919851 2016
218
Association of Admission Laboratory Values and the Timing of Endoscopic Retrograde Cholangiopancreatography With Clinical Outcomes in Acute Cholangitis. 61
27557050 2016
219
[Efficacy of Combined Therapy(Drainage of the Bile Duct, High-Dose Hepatic Artery Infusion, and Radiation)for Hilar Cholangiocellularcarcinoma with Complete Portal Vein Obstruction]. 61
28133065 2016
220
Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent. 61
27029890 2016
221
Acute Cholangitis Management: Prevention of Organ Failure and Death. 61
27556590 2016
222
The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. 61
27506331 2016
223
Efficacy and safety of emergency endoscopic retrograde cholangiopancreatography for acute cholangitis in the elderly. 61
27729744 2016
224
Acute cholangitis: An unexpected cause of fever of unknown origin diagnosed by (18)F-FDG PET/CT. 61
27033744 2016
225
Therapeutic Challenges for Symptomatic Portal Cavernoma Cholangiopathy. 61
27689206 2016
226
Migration of Surgical Clips into the Common Bile Duct after Laparoscopic Cholecystectomy. 61
28203125 2016
227
Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis. 61
27498582 2016
228
A case of adenosquamous carcinoma of the lower bile duct diagnosed preoperatively via transpapillary biopsy. 61
27498940 2016
229
[Spondylocostal dysostosis and acute cholangitis in pediatrics emergency room]. 61
29421389 2016
230
Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2. 61
27347207 2016
231
Clinical features of gallstone impaction at the ampulla of Vater and the effectiveness of endoscopic biliary drainage without papillotomy. 61
27556102 2016
232
Safe laparoscopic clearance of the common bile duct in emergently admitted patients with choledocholithiasis and cholangitis. 61
27212991 2016
233
Gallstones. 61
27121416 2016
234
Liver Hydatid Cyst and Acute Cholangitis: a Case Report. 61
27309273 2016
235
Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report. 61
26968162 2016
236
Intrahepatic Duct Stones Harboring Ascariasis Ova: A Case Report. 61
27015193 2016
237
Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma. 61
26162420 2016
238
[Acute cholangitis in interstenosis space accompanied by two-component unit of the main bile duct]. 61
27263209 2016
239
Mortality Risk for Acute Cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitis. 61
26860903 2016
240
Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13). 61
26961212 2016
241
[The benefit of urgent endoscopic retrograde cholangiopancreatography for the therapy of acute pancreatitis]. 61
27627082 2016
242
Role of Presepsin for the Assessment of Acute Cholangitis Severity. 61
27215088 2016
243
Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. 61
26391268 2016
244
[Malignant biliary obstruction]. 61
26898789 2016
245
[SURGICAL TREATMENT OF ACUTE CHOLANGITIS IN CHOLEDOCHOLITHIASIS]. 61
27249924 2016
246
Choledochoduodenal Fistula after the Placement of a Partially Covered Metal Stent for Unresectable Pancreatic Cancer. 61
27301511 2016
247
Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial. 61
26510180 2015
248
Long-term risk for acute pancreatitis, cholangitis, and malignancy more than 15 years after endoscopic sphincterotomy: a population-based study. 61
26165737 2015
249
Establishment of a novel rat model of severe acute cholangitis. 61
26949501 2015
250
[Recent Advances in the Management of Recurrent Bile Duct Stones]. 61
26586346 2015
251
Endoscopic Extraction of Biliary Fascioliasis Diagnosed Using Intraductal Ultrasonography in a Patient with Acute Cholangitis. 61
26668810 2015
252
Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies. 61
26673862 2015
253
Combined radiological-endoscopic management of difficult bile duct stones: 18-year single center experience. 61
26557890 2015
254
[TG13: THE UPDATED TOKYO'S CLINICAL RECOMMENDATIONS FOR TREATMENT OF AN ACUTE CHOLANGITIS AND CHOLECYSTITIS]. 61
26946649 2015
255
Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy. 61
26895121 2015
256
[Acute cholangitis secondary to ascariasis and complicated by liver abscesses]. 61
26742557 2015
257
Letter: acute cholangitis: understanding predictors of outcome--authors' reply. 61
26278564 2015
258
Letter: acute cholangitis--understanding predictors of outcome. 61
26278563 2015
259
Long-term Outcomes of Symptomatic Gallbladder Sludge. 61
25127114 2015
260
Stenting of the Cystic Duct in Benign Disease: A Definitive Treatment for the Elderly and Unwell. 61
25385254 2015
261
Predictors of prolonged laparoscopic cholecystectomy in the treatment of low-grade acute cholecystitis: a single-center, retrospective, observational study. 61
29123719 2015
262
Hepatocellular carcinoma with bile duct invasion presenting as acute cholangitis. 61
26140647 2015
263
Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. 61
25997554 2015
264
Endoscopic snare papillectomy for a solitary Peutz-Jeghers-type polyp in the duodenum with ingrowth into the common bile duct: Case report. 61
26185397 2015
265
Endoscopic retrograde cholangiopancreatography in ruptured liver hydatid cyst. 61
26345677 2015
266
Gallstone-related disease in the elderly: is there room for improvement? 61
25577265 2015
267
Early versus delayed laparoscopic common bile duct exploration for common bile duct stone-related nonsevere acute cholangitis. 61
26123122 2015
268
Biliary Mucosal Barrier and Microbiome. 61
26468308 2015
269
Risk factors of organ failure in cholangitis with bacteriobilia. 61
26139997 2015
270
Bedside Endoscopic Ultrasound-guided Transgastric Gallbladder Aspiration and Lavage in a High-risk Surgical Case Due to Acute Cholecystitis Accompanied by Multiorgan Failure. 61
26087693 2015
271
Comparison Between Endoscopic Biliary Stenting and Nasobiliary Drainage in Patients with Acute Cholangitis due to Choledocholithiasis: Is Endoscopic Biliary Stenting Useful? 61
26897928 2015
272
Ectopic Opening of the Common Bile Duct into the Duodenal Bulb Accompanied with Cholangitis and Gallbladder Cancer: A Report of Two Cases. 61
26064829 2015
273
The role of per oral cholangiopancreatoscopy (POCPS) in complicated pancreaticobiliary disease. 61
26260560 2015
274
Portal Hypertensive Biliopathy: An Infrequent Cause of Biliary Obstruction. 61
28868376 2015
275
Preventive pancreatic stents in the management of acute biliary pancreatitis (PREPAST trial): pre-study protocol for a multicenter, prospective, randomized, interventional, controlled trial. 61
25754525 2015
276
Adenomas of the common bile duct in familial adenomatous polyposis. 61
25780319 2015
277
Testosterone suppresses hepatic inflammation by the downregulation of IL-17, CXCL-9, and CXCL-10 in a mouse model of experimental acute cholangitis. 61
25672751 2015
278
A unique use of a double-pigtail plastic stent: correction of kinking of the common bile duct due to a metal stent. 61
25721004 2015
279
Identification of risk factors for intraoperative hemobilia and its correlation with early postoperative complications in patients with hepatolithiasis. 61
25190546 2015
280
Risk factors of open converted cholecystectomy for cholelithiasis after endoscopic removal of choledocholithiasis. 61
25228363 2015
281
[Prevention and treatment of complications for full-covered self-expanding removable metal stents in malignant obstructive jaundice]. 61
25916776 2015
282
Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. 61
25649526 2015
283
Feasibility of non-anesthesiologist-administered propofol sedation for emergency endoscopic retrograde cholangiopancreatography. 61
25883644 2015
284
Hepatic peribiliary cysts with rapidly progressive refractory obstructive jaundice and esophageal varices. 61
25748954 2015
285
Acute Cholangitis following Intraductal Migration of Surgical Clips 10 Years after Laparoscopic Cholecystectomy. 61
25874138 2015
286
Severe Acute Cholangitis with Complications of Bacterial Meningitis Associated with Hearing Loss. 61
26179531 2015
287
Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. 61
25593469 2015
288
Primary Amyloidosis Presenting as Common Bile Duct Obstruction With Cholangitis. 61
26157929 2015
289
Acute Cholangitis following Biliary Obstruction after Duodenal OTSC Placement in a Case of Large Chronic Duodenocutaneous Fistula. 61
26185690 2015
290
Indirect Fist Percussion of the Liver Is a More Sensitive Technique for Detecting Hepatobiliary Infections than Murphy's Sign. 61
26788057 2015
291
Small sphincterotomy combined with endoscopic papillary large balloon dilation vs sphincterotomy alone for removal of common bile duct stones. 61
25548495 2014
292
Clinical evaluation of the Tokyo Guidelines 2013 for severity assessment of acute cholangitis. 61
25410528 2014
293
Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia. 61
24898101 2014
294
[Cholelithiasis: complications and rehabilitation]. 61
25675740 2014
295
Is it safer to postpone endoscopic large balloon dilatation after ES in the setting of acute cholangitis due to large bile duct stones? 61
25213080 2014
296
Antioxidative phytoceuticals to ameliorate pancreatitis in animal models: an answer from nature. 61
25469025 2014
297
[Efficacy of percutaneous transhepatic cholangial drainage in the treatment of periampullary carcinoma complicated with acute cholangitis of severe type]. 61
25567315 2014
298
Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. 61
24985067 2014
299
Calculated Antibiosis of Acute Cholangitis and Cholecystitis. 61
26535043 2014
300
Diagnostic accuracy of transient hepatic attenuation differences on computed tomography scans for acute cholangitis in patients with malignant disease. 61
24816796 2014
301
Definitive diagnosis of a duplicate gallbladder can only be made intraoperatively: report of a case. 61
26185884 2014
302
Management of bile duct injuries following laparoscopic cholecystectomy: long-term outcome and risk factors infuencing biliary reconstruction. 61
25149612 2014
303
Delayed endoscopic papillary large balloon dilation after sphincterotomy for removing large bile duct stones in patients with acute cholangitis. 61
24464208 2014
304
The use of proton pump inhibitors and the spectrum and number of biliary pathogens in patients with acute cholangitis. 61
24628434 2014
305
Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years. 61
24870302 2014
306
Endoscopic papillary large balloon dilation vs endoscopic sphincterotomy for retrieval of common bile duct stones: a meta-analysis. 61
24833886 2014
307
Endoscopic Sphincterotomy Using the Rendezvous Technique for Choledocholithiasis during Laparoscopic Cholecystectomy: A Case Report. 61
25298761 2014
308
Acute cholangitis and hemobilia in a patient with liver cirrhosis and portal vein cavernomatous transformation. 61
25287238 2014
309
[Management of acute cholangitis]. 61
24923104 2014
310
Clinicomicrobiological analysis of patients with cholangitis. 61
24713902 2014
311
Inflammatory pseudotumor of the liver: a rare case of recurrence following surgical resection. 61
24967025 2014
312
Comparison of emergent versus elective laparoscopic common bile duct exploration for patients with or without nonsevere acute cholangitis complicated with common bile duct stones. 61
24398306 2014
313
[Clinical vignette. Diagnosis of acute cholangitis]. 61
24830217 2014
314
An association of elevated levels of alkaline phosphatase and gamma-glutamyl transpeptidase with acute cholangitis. 61
24901126 2014
315
Factors predicting adverse short-term outcomes in patients with acute cholangitis undergoing ERCP: A single center experience. 61
24634711 2014
316
Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? 61
24634710 2014
317
Severity and prognostic assessment of the endotoxin activity assay in biliary tract infection. 61
23798326 2014
318
Natural history of portal cavernoma cholangiopathy. 61
25755597 2014
319
Portal cavernoma cholangiopathy-clinical characteristics. 61
25755593 2014
320
Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. 61
25755591 2014
321
[Mini-invasive interventions for biliary calculous disease complicated by acute cholangitis and mechanical jaundice]. 61
24923129 2014
322
Re: TG13 antimicrobial therapy for acute cholangitis and cholecystitis. 61
24449559 2014
323
Risk factors for increased antimicrobial resistance: a retrospective analysis of 309 acute cholangitis episodes. 61
24084640 2014
324
Response to re: TG13 antimicrobial therapy for acute cholangitis and cholecystitis. 61
24449560 2014
325
Comparison of two editions of Tokyo guidelines for the management of acute cholangitis. 61
23813895 2014
326
Endoscopic nasobiliary drainage with sphincterotomy in acute obstructive cholangitis: a prospective randomized controlled trial. 61
24131862 2014
327
Total rupture of hydatid cyst of liver in to common bile duct: a case report. 61
25932083 2014
328
Analyzing risk factors for early postoperative bile leakage based on Clavien classification in bile duct stones. 61
24909135 2014
329
Comparison of Laboratory Data of Acute Cholangitis Patients Treated with or without Immunosuppressive Drugs. 61
24734189 2014
330
Association between juxtapapillary diverticulum and acute cholangitis determined using laboratory data. 61
25429235 2014
331
Ampullary tumor presenting as acute cholangitis. 61
24975588 2014
332
Endoscopic retrograde cholangiopancreatography at Dhulikhel Hospital: outcome analysis. 61
25219996 2014
333
Histiocytic sarcoma of the bile duct. 61
24694481 2014
334
Late Complications following Endoscopic Sphincterotomy for Choledocholithiasis: A Swedish Population-Based Study. 61
25386097 2014
335
Histopathologic distinction between fibrosing cholestatic hepatitis C and biliary obstruction. 61
24061518 2013
336
Endoscopic plastic stenting for bile duct stones: stent changing on demand or every 3 months. A prospective comparison study. 61
24288221 2013
337
Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis. 61
24334691 2013
338
Updates in bacteriological epidemiology of community-acquired severe acute cholangitis and the effectiveness of metronidazole added routinely to the first-line antimicrobial regimen. 61
23708782 2013
339
Does prophylactic stent insertion to the common bile duct during endoscopic retrograde cholangiopancreatography (ERCP) before cholecystectomy have any impact on the rate of biliary complications? 61
23860609 2013
340
Long-term outcome of the WallFlex partially covered stent for unresectable malignant biliary obstruction: a multicenter single-arm prospective study. 61
24088309 2013
341
Multidetector CT of emergent biliary pathologic conditions. 61
24224584 2013
342
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity. 61
24172289 2013
343
Erratum to: Endotoxin adsorption therapy using polymyxin B-immobilized fiber as a treatment for septic shock-associated severe acute cholangitis. 61
26181839 2013
344
Endotoxin adsorption therapy using polymyxin B-immobilized fiber as a treatment for septic shock-associated severe acute cholangitis. 61
26181837 2013
345
Acute biliary conditions. 61
24160931 2013
346
Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis. 61
24629813 2013
347
Biliary ascariasis in a bile duct stones-removed female patient. 61
24106417 2013
348
American College of Gastroenterology guideline: management of acute pancreatitis. 61
23896955 2013
349
Significance of peribiliary oedema on computed tomography in diagnosis and severity assessment of acute cholangitis. 61
23806530 2013
350
Education and Imaging. Hepatobiliary and pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis. 61
23875637 2013
351
Spectrum of pathogens in acute cholangitis in patients with and without biliary endoprosthesis. 61
23603487 2013
352
Verification of the Tokyo guidelines for acute cholangitis secondary to benign and malignant biliary obstruction: experience from a Chinese tertiary hospital. 61
23924498 2013
353
Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy. 61
23919218 2013
354
Management for CBD stone-related mild to moderate acute cholangitis: urgent versus elective ERCP. 61
23456495 2013
355
ERCP in acute cholangitis during third trimester of pregnancy. 61
23425808 2013
356
Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis. 61
23528654 2013
357
Beware of gossypibomas. 61
23813518 2013
358
[Endoscopic papillary balloon dilatation vs. endoscopic sphincteropapillotomy for common bile duct stones: a meta analysis]. 61
24151660 2013
359
Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy. 61
23840129 2013
360
Use of antithrombin and thrombomodulin in the management of disseminated intravascular coagulation in patients with acute cholangitis. 61
23710320 2013
361
[A case of infected subdural hematoma accompanied by cerebral infarction]. 61
23648657 2013
362
Enterolith causing acute afferent loop syndrome after Billroth II gastrectomy: a case report. 61
23837955 2013
363
Direct biliary drainage using transnasal endoscopy for patients with severe-to-moderate acute cholangitis. 61
23278442 2013
364
Risk factors of organ failure in patients with bacteremic cholangitis. 61
23179153 2013
365
Management hepatolithiasis with operative choledochoscopic FREDDY laser lithotripsy combined with or without hepatectomy. 61
23558070 2013
366
[Criteria of diagnosis and principles of treatment of obturation jaundice and its complicated forms--an acute cholangitis and biliary sepsis]. 61
23718023 2013
367
Percutaneous transhepatic biliary drainage using a ligated catheter for recurrent catheter obstruction: antireflux technique. 61
23560165 2013
368
Endoscopic lithotripsy with peroral direct cholangioscopy using a conventional endoscope. 61
23515588 2013
369
Efficacy and safety of ERCP in a low-volume hospital. 61
23659504 2013
370
Diagnostic and therapeutic value of ERCP in acute cholangitis. 61
23997958 2013
371
TG13 flowchart for the management of acute cholangitis and cholecystitis. 61
23307003 2013
372
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). 61
23307001 2013
373
A large impacted pancreatic duct stone causing acute cholangitis. 61
24163184 2013
374
TG13 management bundles for acute cholangitis and cholecystitis. 61
23307002 2013
375
TG13 antimicrobial therapy for acute cholangitis and cholecystitis. 61
23340954 2013
376
Acute cholangitis due to anomaly of right hepatic artery. 61
24442549 2013
377
Disparities in outcomes following admission for cholangitis. 61
23555680 2013
378
Acute cholangitis associated with ceftriaxone therapy. 61
23370755 2013
379
TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. 61
23307004 2013
380
TG13 miscellaneous etiology of cholangitis and cholecystitis. 61
23307005 2013
381
Genetics of gallstone disease. 61
23724744 2013
382
One-step, simultaneous triple endoscopic nasobiliary drainage for hilar biliary stricture. 61
23286260 2013
383
Metastatic leiomyosarcoma of the intrapancreatic bile duct. 61
23323239 2013
384
A new anastomosis method for choledochojejunostomy by the way behind antrue pyloricum. 61
24342302 2013
385
Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study. 61
23073141 2013
386
TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. 61
23307006 2013
387
TG13 indications and techniques for biliary drainage in acute cholangitis (with videos). 61
23307008 2013
388
Usefulness of procalcitonin for severity assessment in patients with acute cholangitis. 61
23505924 2013
389
[Simultaneous surgical mithral-tricuspidal insufficiency correction and cholecystectomy with choledocholithotomy by acute cholangitis]. 61
23503357 2013
390
Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence. 61
23762626 2013
391
TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). 61
23340953 2013
392
Needle knife precut papillotomy and fistulotomy for difficult biliary cannulation during endoscopic retrograde cholangiopancreatography. 61
23989041 2013
393
Comparison of the clinical characteristics and imaging findings of acute cholangitis with and without biliary dilatation. 61
23175488 2012
394
Endoscopic sphincterotomy associated cholangitis in patients receiving proximal biliary self-expanding metal stents. 61
23232637 2012
395
Risk factors and incidence of acute pyogenic cholangitis. 61
23232638 2012
396
Taenia saginata a rare cause of acute cholangitis: a case report. 61
23340150 2012
397
Comparison of complication outcomes in acute pancreatitis following ERCP and conservative management at UKM medical centre: a six years retrospective study. 61
23306739 2012
398
Proposed new simple scoring system to identify indications for urgent ERCP in acute cholangitis based on the Tokyo Guidelines. 61
22203454 2012
399
Comparative study of rendezvous techniques in post-liver transplant biliary stricture. 61
23139613 2012
400
Caudate lobe-sparing subtotal hepatectomy for primary hepatolithiasis. 61
22961524 2012
401
Assessment of acute cholangitis by MR imaging. 61
22088387 2012
402
[Primary T cell lymphoma of the pancreas: clinical case report]. 61
23307095 2012
403
Severe acute cholangitis after endoscopic sphincterotomy induced by barium examination: A case report. 61
23112564 2012
404
Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. 61
22507875 2012
405
Prospective comparative study of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for removal of large bile duct stones in patients above 45 years of age. 61
22934594 2012
406
Effectiveness of combined biliary and duodenal stenting in patients with malignant biliary and duodenal obstruction. 61
22571283 2012
407
[Urgent endoscopic retrograde cholangio-pancreatography: to whom, when and how to perform?]. 61
22961415 2012
408
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. 61
22872303 2012
409
Factors involved in resistance to early treatment of acute cholangitis patients. 61
22193432 2012
410
New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. 61
22825491 2012
411
Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines. 61
22825492 2012
412
Whereabouts of an internal short stent placed across the pancreaticojejunostomy following pancreatoduodenectomy. 61
22869100 2012
413
Laparoscopic left hepatectomy in patients with intrahepatic duct stones and recurrent pyogenic cholangitis. 61
26388917 2012
414
[The Caroli's disease. Report of 16 cases]. 61
22987378 2012
415
Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. 61
22826624 2012
416
Verification of Tokyo Guidelines for diagnosis and management of acute cholangitis. 61
22033865 2012
417
Diagnostic performance of multidetector CT for acute cholangitis: evaluation of a CT scoring method. 61
21791504 2012
418
Is antibiotic resistance microorganism becoming a significant problem in acute cholangitis in Korea? 61
22866247 2012
419
Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis. 61
22866257 2012
420
Use of a partially covered self-expandable metallic stent to treat a biliary stricture secondary to chronic pancreatitis complicated by recurrent cholangitis: a case report. 61
22533753 2012
421
Successful treatment of benign biliary stricture by a covered self-expandable metallic stent in a patient with chronic pancreatitis. 61
22533751 2012
422
Percutaneous transhepatic cholecystostomy for choledocholithiasis with acute cholangitis in high-risk patients. 61
21940369 2012
423
An impacted pancreatic stone in the papilla induced acute obstructive cholangitis in a patient with chronic pancreatitis. 61
22741140 2012
424
Role of magnetic resonance cholangiopancreatography for choledocholithiasis: analysis of patients with negative MRCP. 61
22149906 2012
425
Validation of the Lacaine-Huguier predictive score for choledocholithiasis: prospective study of 380 patients. 61
22310294 2012
426
[A case of afferent loop syndrome with acute cholangitis developed after percutaneous transhepatic cholangioscopic lithotripsy for treatment of choledocholithiasis in a patient who underwent Billroth II gastrectomy]. 61
22387838 2012
427
Clinicopathologic features of q Fever patients with acute hepatitis. 61
23109972 2012
428
Enterococcus hirae-related acute pyelonephritis and cholangitis with bacteremia: an unusual infection in humans. 61
22313539 2012
429
Effects of endoscopic sphincterotomy on biliary epithelium: a case-control study. 61
22371639 2012
430
Acute cholangitis secondary to a recently migrated cystic duct clip, 15 years after cholecystectomy. 61
22933262 2012
431
An unusual cause of biliary obstruction. 61
22844197 2012
432
Oriental cholangiohepatitis masquerading as cholangiocarcinoma: A rare presentation that surgeons need to know. 61
22503913 2012
433
Melioidosis in acute cholangitis of diabetic patient: a forgotten diagnosis. 61
30100777 2012
434
Laproscopic management of wandering biliary ascariasis. 61
22973531 2012
435
Biliary fascioliasis--an uncommon cause of recurrent biliary colics: report of a case and brief review. 61
22566787 2012
436
Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer. 61
22340475 2012
437
[Complications of endoscopic retrograde cholangiopancreatography and how to minimize them]. 61
22277041 2011
438
Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage. 61
21842232 2011
439
A descriptive study evaluating the circumstances of medical treatment for acute pancreatitis before publication of the new JPN guidelines based on the Japanese administrative database associated with the Diagnosis Procedure Combination system. 61
21431888 2011
440
Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus. 61
20215482 2011
441
Early bile duct cancer detected by direct peroral cholangioscopy with narrow-band imaging after bile duct stone removal. 61
21927669 2011
442
Microbial profile and antibiotic sensitivity pattern in acute bacterial cholangitis. 61
22006165 2011
443
Life-threatening hemorrhage from the papilla following stent removal (with video). 61
21516335 2011
444
Atypical presentation of Wilson disease. 61
21901661 2011
445
Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. 61
21504380 2011
446
Role of radial endosonography in the diagnosis of acute cholangitis. 61
21221785 2011
447
Foregut cystic malformations in the pancreas. Are definitions clearly established? 61
21737908 2011
448
A case of severe acute pancreatitis and cholangitis presenting as initial complaints of hepatocellular carcinoma. 61
21873799 2011
449
[Biliary lithiasis]. 61
21397448 2011
450
Charcot's triad. 61
21584209 2011
451
Diagnosis and management of acute cholangitis. 61
21207254 2011
452
Surgical treatment of pancreatic neuroendocrine tumours - clinical experience. 61
22166361 2011
453
Portal vein arterialization in liver transplantation: an option to restore arterial flow: a case report. 61
21486592 2011
454
Clinical efficacy of i.v. doripenem, a new class of carbapenem, in patients with biliary tract infection: A multicenter trial. 61
21426451 2011
455
[Safety and efficacy of endoscopic retrograde cholangiopancreatograpy in very elderly patients]. 61
21519177 2011
456
An observational study using a national administrative database to determine the impact of hospital volume on compliance with clinical practice guidelines. 61
21263358 2011
457
Accuracy of the Tokyo Guidelines for the diagnosis of acute cholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. 61
21042814 2011
458
Endoscopic ultrasonography-guided gallbladder drainage: actual technical presentations and review of the literature (with videos). 61
20652716 2011
459
Pathogenesis of cholangitis in obstructive jaundice-revisited. 61
21372774 2011
460
Management of acute cholangitis. 61
21475420 2011
461
Treatment of acute cholangitis with hepatolithiasis. 61
21375946 2011
462
[The method of biliary tracts drainage of patients with biliodigestive anastomosis at obstructive jaundice and acute cholangitis]. 61
21350398 2011
463
Evaluation of compliance with the Tokyo Guidelines for the management of acute cholangitis based on the Japanese administrative database associated with the Diagnosis Procedure Combination system. 61
20607569 2011
464
A case of cholestatic hepatitis associated with histologic features of acute cholangitis. 61
22162934 2011
465
[Hepatitis E virus: A new entity]. 61
21167429 2010
466
Obstructive jaundice caused by a portal cavernoma. 61
21191741 2010
467
Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature. 61
21332006 2010
468
[A case of portal vein thrombosis complicating acute cholangitis treated successfully with danaparoid sodium]. 61
21071899 2010
469
Optimal timing of elective laparoscopic cholecystectomy after acute cholangitis and subsequent clearance of choledocholithiasis. 61
20381787 2010
470
Impact of hospital volume on clinical outcomes of endoscopic biliary drainage for acute cholangitis based on the Japanese administrative database associated with the diagnosis procedure combination system. 61
20502923 2010
471
Ultrathin endoscope-assisted ERCP for inaccessible peridiverticular papilla by a single-balloon enteroscope in a patient with Roux-en-Y anastomosis. 61
21175491 2010
472
Bile-Duct Stone Removal under Direct Transnasal Cholangioscopy Using an Ultraslim Upper Endoscope. 61
20981228 2010
473
[Unusual location of a bronchogenic cyst simulating a pancreatic tumor]. 61
20483441 2010
474
What are the risk factors for acute suppurative cholangitis caused by common bile duct stones? 61
20981214 2010
475
[Acute cholangitis]. 61
21130926 2010
476
Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow-up. 61
20630514 2010
477
An unusual cause of acute cholangitis. 61
20683971 2010
478
Endoscopic retrograde cholangiopancreatography using a single-balloon enteroscope in patients with altered Roux-en-Y anatomy. 61
20589594 2010
479
[Unusual presentation of autoimmune pancreatitis type 1]. 61
20721841 2010
480
Concomitant Rupture of Hydatid Cyst of Liver in Hepatic Duct and Gallbladder: Case Report. 61
27942301 2010
481
Successful endoscopic extraction of a large impacted choledocholithiasis in the ampulla of vater: two interesting cases. 61
20590755 2010
482
Comparative study on presentation of biliary ascariasis with dead and living worms. 61
20616417 2010
483
Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. 61
19779305 2010
484
Case review of impacted bile duct stone at duodenal papilla: detection and endoscopic treatment. 61
20499418 2010
485
Paravaterian diverticula presenting as acute cholangitis in two very elderly patients. 61
20593062 2010
486
Significance of MD-2 and MD-2B expression in rat liver during acute cholangitis. 61
21161002 2010
487
[A clinicopathologic study of biliary intraductal papillary neoplasm]. 61
20646655 2010
488
Characteristics of delayed hemorrhage after endoscopic sphincterotomy. 61
20074163 2010
489
Usefulness of the rendezvous technique for biliary stricture after adult right-lobe living-donor liver transplantation with duct-to-duct anastomosis. 61
20479915 2010
490
Transnasal endoscopic biliary drainage as a rescue management for the treatment of acute cholangitis. 61
21160690 2010
491
Laparoscopic common bile duct exploration: our first 50 cases. 61
20237736 2010
492
[A rare cause of obstructive jaundice: fascioliasis]. 61
21391191 2010
493
Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? A prospective, randomized trial. 61
19913785 2010
494
Long-term outcomes of choledochoduodenostomy for hepatolithiasis. 61
20137359 2010
495
WITHDRAWN. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. 61
20091549 2010
496
[Role and indications of ERCP in treatment of acute biliary pancreatitis]. 61
21387770 2010
497
Treatment strategy for acute pancreatitis. 61
20012325 2010
498
Endoscopic management of acute cholecystitis and cholangitis caused by limy bile. 61
20431775 2009
499
Diagnostic and therapeutic procedure with a short double-balloon enteroscope and cholangioscopy in a patient with acute cholangitis due to hepatolithiasis. 61
19559432 2009
500
[A case of congenital hepatic fibrosis presented with recurrent acute cholangitis]. 61
20026897 2009
501
Bedside ERCP without fluoroscopy in a case with acute cholangitis and impaired general status. 61
20084582 2009
502
Biliary cannulation facilitated by endoscopic clip assistance in the setting of intra-diverticular papilla. 61
20084573 2009
503
[Endoscopic diagnostics and management of pancreatic-biliary disorders in patients after Billroth II gastric resection]. 61
20017435 2009
504
Acute cholangitis due to pancreatic metastasis from squamous cell lung carcinoma: a case report and review of literature. 61
20062690 2009
505
Clinical role of frequency-doubled double-pulsed yttrium aluminum garnet laser technology for removing difficult bile duct stones (with videos). 61
19573867 2009
506
Is Oddi sphincterotomy an indication for hepatolithiasis? 61
19184214 2009
507
Diagnosis and management of acute cholangitis. 61
19652653 2009
508
Endoscopic retrograde cholangiopancreatography during pregnancy without radiation. 61
19653343 2009
509
Acute cholangitis due to afferent loop syndrome after a Whipple procedure: a case report. 61
19918578 2009
510
Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement. 61
19539920 2009
511
Nationwide epidemiological study of severe gallstone disease in Taiwan. 61
19698126 2009
512
Laparoscopic exploration of the common bile duct and removal of dead worm in a patient of cholangitis after endoscopic retrograde cholangiopancreatography failure. 61
20040804 2009
513
Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis. 61
18807184 2009
514
Triggering receptor in myeloid cells (TREM-1) specific expression in peripheral blood mononuclear cells of sepsis patients with acute cholangitis. 61
19396532 2009
515
Transient arterial enhancement of the hepatic parenchyma in patients with acute cholangitis. 61
19478633 2009
516
Bacteribilia after preoperative bile duct stenting: a prospective study. 61
19276992 2009
517
[Mycobacterium kansasii infection after liver transplantation]. 61
19371974 2009
518
Surgical management for acute cholangitis in patient with a left lobe liver lesion. 61
19385299 2009
519
[Retrospective presentation of 255 episodes of acute cholangitis in our context]. 61
19492909 2009
520
Removal of a large stone growing around and encasing a plastic biliary stent: respect the ductal axis. 61
18083076 2009
521
Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. 61
19054383 2009
522
Acute obstructive cholangitis after transarterial chemoembolization: the effect of percutaneous transhepatic removal of tumor fragment. 61
19270868 2009
523
Critical care of the patient with acute pancreatitis. 61
19400483 2009
524
Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. 61
19212308 2009
525
Laparoscopically assisted ERCP in a case of acute cholangitis in a patient with biliopancreatic diversion with distal gastric preservation. 61
18815847 2009
526
Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis. 61
18769362 2009
527
[Cholangitis and biliary sepsis: problem and ways of solution]. 61
19663273 2009
528
Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case. 61
19280286 2009
529
[Diagnosis: acute cholangitis and pancreatitis secondary to impacted choledocholithiasis in the ampulla of Vater]. 61
19480072 2009
530
Efficacy of preoperative endoscopic nasobiliary drainage for hilar cholangiocarcinoma. 61
19300895 2009
531
Comparison between emergency and elective endoscopic sphincterotomy in patients with acute cholangitis due to choledocholithiasis: is emergency endoscopic sphincterotomy safe? 61
19597758 2009
532
Feasibility of therapeutic endoscopic retrograde cholangiopancreatography for bile duct stones in nonagenarians: a single unit audit. 61
19104704 2008
533
[Bile duct cysts in adults: surgical procedure]. 61
19080910 2008
534
Should urgent ERCP be performed in patients with acute biliary pancreatitis without acute cholangitis? 61
18628734 2008
535
Efficacy and safety of 1-step transnasal endoscopic nasobiliary drainage for the treatment of acute cholangitis in patients with previous endoscopic sphincterotomy (with videos). 61
18423630 2008
536
Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. 61
18570948 2008
537
Viral infections of the biliary tract. 61
19568530 2008
538
Ectopic openings of the bilio-pancreatic ducts in the stomach in an elderly case presenting with choledocholithiasis and acute cholangitis. 61
18568154 2008
539
Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiasis: a tropical experience. 61
18839486 2008
540
Transient marked elevation of serum CA 19-9 levels in a patient with acute cholangitis and biliary stent. 61
18528223 2008
541
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. 61
18506921 2008
542
Activation of TLR-4 and liver injury via NF-kappa B in rat with acute cholangitis. 61
18397856 2008
543
[Liver resection in the treatment of intrahepatic lithiasis. Immediate and long-term results in a single-center series]. 61
18563980 2008
544
Portal vein thrombosis in cats: 6 cases (2001-2006). 61
18371022 2008
545
Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction. 61
17704880 2008
546
Considerations concerning laparoscopic cholecystectomy in the extremely elderly. 61
18266576 2008
547
Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. 61
18216529 2008
548
Initial experience of transnasal endoscopic biliary drainage without conscious sedation for the treatment of acute cholangitis (with video). 61
18226697 2008
549
[Areflux choledochoduodenostomy in surgery of acute cholangitis]. 61
19069820 2008
550
[Postoperative handling in biliodigestive derivation by iatrogenic bile duct injury]. 61
18792670 2008
551
[Local permanent intraarterial antimicrobic therapy in postoperative period at the patients with cholangitis]. 61
18427466 2008
552
Pancreaticobiliary malunion and incomplete pancreas divisum: an unusual cause of common bile duct obstruction. 61
18467273 2008
553
Interval percutaneous cholecystostomy is effective for decompression of the common bile duct in high-risk elderly patients prior to endoscopic retrograde cholangiopancreatography. 61
18309228 2008
554
[Acute cholangitis]. 61
18303790 2007
555